688161 威高骨科
交易中 04-30 14:22:09
资讯
新帖
简况
图解威高骨科一季报:第一季度单季净利润同比下降14.60%
证券之星 · 04-29 18:27
图解威高骨科一季报:第一季度单季净利润同比下降14.60%
威高骨科(688161)3月31日股东户数0.96万户,较上期减少3.78%
证券之星 · 04-29 17:42
威高骨科(688161)3月31日股东户数0.96万户,较上期减少3.78%
东吴证券:给予威高骨科买入评级
证券之星 · 04-06
东吴证券:给予威高骨科买入评级
股市必读:威高骨科年报 - 第四季度单季净利润同比增长2.99%
证券之星 · 03-30
股市必读:威高骨科年报 - 第四季度单季净利润同比增长2.99%
威高骨科(688161)2025年年报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 03-29
威高骨科(688161)2025年年报简析:营收净利润同比双双增长,公司应收账款体量较大
威高骨科(688161)2月28日股东户数1万户,较上期减少1.01%
证券之星 · 03-28
威高骨科(688161)2月28日股东户数1万户,较上期减少1.01%
图解威高骨科年报:第四季度单季净利润同比增长2.99%
证券之星 · 03-28
图解威高骨科年报:第四季度单季净利润同比增长2.99%
每周股票复盘:威高骨科(688161)完成董事会换届及高管聘任
证券之星 · 03-22
每周股票复盘:威高骨科(688161)完成董事会换届及高管聘任
威高骨科(688161)披露与私募基金合作投资进展公告,3月20日股价下跌4.14%
证券之星 · 03-20
威高骨科(688161)披露与私募基金合作投资进展公告,3月20日股价下跌4.14%
威高骨科(688161)披露2026年第一次临时股东会决议公告,3月16日股价下跌0.32%
证券之星 · 03-16
威高骨科(688161)披露2026年第一次临时股东会决议公告,3月16日股价下跌0.32%
威高骨科(688161)披露2026年第一次临时股东会会议资料,3月6日股价上涨2.82%
证券之星 · 03-06
威高骨科(688161)披露2026年第一次临时股东会会议资料,3月6日股价上涨2.82%
威高股份(01066):威高骨科(688161.SH)2025年度归母净利润2.67亿元 同比增长19.17%
智通财经 · 02-27
威高股份(01066):威高骨科(688161.SH)2025年度归母净利润2.67亿元 同比增长19.17%
威高骨科(688161)披露召开2026年第一次临时股东大会通知,2月26日股价下跌0.81%
证券之星 · 02-26
威高骨科(688161)披露召开2026年第一次临时股东大会通知,2月26日股价下跌0.81%
每周股票复盘:威高骨科(688161)拟出资6000万参投私募基金
证券之星 · 01-18
每周股票复盘:威高骨科(688161)拟出资6000万参投私募基金
威高骨科(688161)披露与私募基金合作投资事项进展公告,1月13日股价上涨0.26%
证券之星 · 01-13
威高骨科(688161)披露与私募基金合作投资事项进展公告,1月13日股价上涨0.26%
每周股票复盘:威高骨科(688161)拟变更募投项目收购杰思拜尔
证券之星 · 01-02
每周股票复盘:威高骨科(688161)拟变更募投项目收购杰思拜尔
威高骨科(688161)披露变更部分募投项目并收购苏州杰思拜尔股权,12月29日股价下跌0.49%
证券之星 · 2025-12-29
威高骨科(688161)披露变更部分募投项目并收购苏州杰思拜尔股权,12月29日股价下跌0.49%
威高骨科(688161)披露拟变更部分募投项目用于收购杰思拜尔55%股权,12月22日股价下跌0.18%
证券之星 · 2025-12-22
威高骨科(688161)披露拟变更部分募投项目用于收购杰思拜尔55%股权,12月22日股价下跌0.18%
威高骨科(688161)披露设立募集资金专项账户议案,12月17日股价上涨0.91%
证券之星 · 2025-12-17
威高骨科(688161)披露设立募集资金专项账户议案,12月17日股价上涨0.91%
威高骨科(688161)披露拟变更部分募投项目并收购杰思拜尔股权,12月11日股价下跌1.06%
证券之星 · 2025-12-11
威高骨科(688161)披露拟变更部分募投项目并收购杰思拜尔股权,12月11日股价下跌1.06%
加载更多
公司概况
公司名称:
山东威高骨科材料股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-06-30
主营业务:
山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发,生产和销售。公司的主要产品是骨科植入物及耗材类产品、骨科智能设备与耗材类产品、功能修复与组织再生类产品。公司是国内产品线最全、规模领先的头部企业之一,市场份额增长远超行业平均增速。公司在国内市场上建立了较高的品牌知名度,在国产高端医疗器械领域具有较高的市场占有率。
发行价格:
36.22
{"stockData":{"symbol":"688161","market":"SH","secType":"STK","nameCN":"威高骨科","latestPrice":27.8,"timestamp":1777530129000,"preClose":29.4,"halted":0,"volume":5490219,"delay":0,"changeRate":-0.0544,"floatShares":400000000,"shares":400000000,"eps":0.6528,"marketStatus":"交易中","change":-1.6,"latestTime":"04-30 14:22:09","open":29.2,"high":29.2,"low":27.6,"amount":154000000,"amplitude":0.0544,"askPrice":27.81,"askSize":14,"bidPrice":27.8,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.6528,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777532400000},"marketStatusCode":2,"adr":0,"adjPreClose":29.4,"symbolType":"stock_kcb","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":32.34,"lowLimit":26.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":400000000,"isCdr":false,"pbRate":2.84,"roa":"--","peRate":42.585784,"roe":"1.06%","epsLYR":0.68,"committee":0.647059,"marketValue":11120000000,"turnoverRate":0.0137,"status":1,"floatMarketCap":11120000000},"requestUrl":"/m/hq/s/688161","defaultTab":"news","newsList":[{"id":"2631659441","title":"图解威高骨科一季报:第一季度单季净利润同比下降14.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631659441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631659441?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:27","pubTimestamp":1777458431,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科2026年一季报显示,一季度公司主营收入2.96亿元,同比上升2.12%;归母净利润4422.96万元,同比下降14.6%;扣非净利润4086.71万元,同比下降16.71%;负债率18.53%,投资收益619.81万元,财务费用-20.52万元,毛利率60.48%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900058855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631966395","title":"威高骨科(688161)3月31日股东户数0.96万户,较上期减少3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631966395","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631966395?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:42","pubTimestamp":1777455762,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科披露,截至2026年3月31日公司股东户数为9603.0户,较2月28日减少377.0户,减幅为3.78%。在医疗器械行业个股中,威高骨科股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2026年2月28日至2026年3月31日,威高骨科区间涨幅为1.28%,在此期间股东户数减少377.0户,减幅为3.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625199625","title":"东吴证券:给予威高骨科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625199625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625199625?lang=zh_cn&edition=full","pubTime":"2026-04-06 07:35","pubTimestamp":1775432114,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对威高骨科进行研究并发布了研究报告《骨科平台型公司,全球化布局提速》,给予威高骨科买入评级。 盈利预测与投资评级:考虑到公司并购整合后费用可能略有增加,我们将公司2026-2027年归母净利润由3.64/4.20亿元下调至3.36/4.14亿元,预计2028年归母净利润为5.01亿元,对应当前市值的PE分别为36/29/24倍,考虑到公司海外发展顺利,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600000116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535715","title":"股市必读:威高骨科年报 - 第四季度单季净利润同比增长2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535715","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623535715?lang=zh_cn&edition=full","pubTime":"2026-03-30 02:25","pubTimestamp":1774808712,"startTime":"0","endTime":"0","summary":"来自:威高骨科2025年归母净利润同比增长20.06%,第四季度营收增速达12.75%。股本股东变化股东户数变动近日威高骨科披露,截至2026年2月28日公司股东户数为9980.0户,较12月31日减少102.0户,减幅为1.01%。2025年度董事会工作报告山东威高骨科材料股份有限公司2025年度董事会工作报告显示,公司实现营业收入152,279.40万元,同比增长4.82%;归属于上市公司股东的净利润26,864.35万元,同比增长20.06%;经营活动现金流量净额41,541.71万元,同比增长51.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623133505","title":"威高骨科(688161)2025年年报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2623133505","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623133505?lang=zh_cn&edition=full","pubTime":"2026-03-29 06:14","pubTimestamp":1774736065,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期威高骨科发布2025年年报。本报告期威高骨科公司应收账款体量较大,当期应收账款占最新年报归母净利润比达107.53%。去年的净利率为17.98%,算上全部成本后,公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622638522","title":"威高骨科(688161)2月28日股东户数1万户,较上期减少1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622638522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622638522?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:04","pubTimestamp":1774688674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科披露,截至2026年2月28日公司股东户数为9980.0户,较12月31日减少102.0户,减幅为1.01%。在医疗器械行业个股中,威高骨科股东户数低于行业平均水平,截至2月28日,医疗器械行业平均股东户数为2.16万户。从股价来看,2025年12月31日至2026年2月28日,威高骨科区间涨幅为8.88%,在此期间股东户数减少102.0户,减幅为1.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622874122","title":"图解威高骨科年报:第四季度单季净利润同比增长2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622874122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622874122?lang=zh_cn&edition=full","pubTime":"2026-03-28 01:38","pubTimestamp":1774633095,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科2025年年报显示,当年度公司主营收入15.23亿元,同比上升4.82%;归母净利润2.69亿元,同比上升20.06%;扣非净利润2.55亿元,同比上升20.77%;其中2025年第四季度,公司单季度主营收入4.17亿元,同比上升12.75%;单季度归母净利润6123.78万元,同比上升2.99%;单季度扣非净利润6023.02万元,同比上升16.81%;负债率17.82%,投资收益3092.44万元,财务费用-955.91万元,毛利率64.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800003737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621791580","title":"每周股票复盘:威高骨科(688161)完成董事会换届及高管聘任","url":"https://stock-news.laohu8.com/highlight/detail?id=2621791580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621791580?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:30","pubTimestamp":1774121434,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,威高骨科报收于28.28元,较上周的31.44元下跌10.05%。本周,威高骨科3月17日盘中最高价报32.07元。公司公告汇总:威高骨科参与设立的私募基金已完成备案,备案编码SBRA30。公司公告汇总山东威高骨科材料股份有限公司于2026年3月16日召开第四届董事会第一次会议,选举陈敏女士为公司第四届董事会董事长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620439784","title":"威高骨科(688161)披露与私募基金合作投资进展公告,3月20日股价下跌4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620439784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620439784?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:42","pubTimestamp":1773999761,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,威高骨科报收于28.28元,较前一交易日下跌4.14%,最新总市值为113.12亿元。该股当日开盘29.54元,最高29.88元,最低28.23元,成交额达7343.78万元,换手率为0.64%。近日,山东威高骨科材料股份有限公司披露《与私募基金合作投资进展公告》。该合伙企业已在中国证券投资基金业协会完成私募投资基金备案登记,备案编码SBRA30,备案日期为2026年3月18日。目前该合伙企业尚未有具体对外投资项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000031028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619464709","title":"威高骨科(688161)披露2026年第一次临时股东会决议公告,3月16日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619464709?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:54","pubTimestamp":1773672854,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘,威高骨科报收于31.34元,较前一交易日下跌0.32%,最新总市值为125.36亿元。该股当日开盘31.44元,最高31.69元,最低31.04元,成交额达5169.88万元,换手率为0.41%。公告显示,公司于2026年3月16日召开2026年第一次临时股东会,会议由董事会召集,董事长陈敏女士主持,采用现场与网络投票结合方式召开。出席会议股东共45人,代表有表决权股份总数333,803,915股,占公司总表决权股份的83.4510%。所有议案均获通过,无反对或弃权导致未通过议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600037238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617563618","title":"威高骨科(688161)披露2026年第一次临时股东会会议资料,3月6日股价上涨2.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617563618","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617563618?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:50","pubTimestamp":1772808624,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,威高骨科报收于29.54元,较前一交易日上涨2.82%,最新总市值为118.16亿元。近日,山东威高骨科材料股份有限公司披露《2026年第一次临时股东会会议资料》。公告显示,公司拟召开2026年第一次临时股东会,审议董事薪酬(津贴)议案,其中独立董事津贴为12万元/年(税前),非独立董事按岗位及绩效确定薪酬;同时审议选举第四届董事会非独立董事及独立董事候选人,采用累积投票制。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600040625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614858885","title":"威高股份(01066):威高骨科(688161.SH)2025年度归母净利润2.67亿元 同比增长19.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614858885","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614858885?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:56","pubTimestamp":1772193407,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份 发布发布山东威高骨科材料股份有限公司2025年度业绩快报,该公司取得营业收入15.39亿元,同比增长5.95%;归属于母公司所有者的净利润2.67亿元,同比增长19.17%;基本每股收益0.67元。公告称,报告期内,骨科带量采购总体执行平稳,国产头部品牌市场份额持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01066","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614056023","title":"威高骨科(688161)披露召开2026年第一次临时股东大会通知,2月26日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614056023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614056023?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:00","pubTimestamp":1772118045,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,威高骨科报收于29.31元,较前一交易日下跌0.81%,最新总市值为117.24亿元。该股当日开盘29.5元,最高29.55元,最低29.07元,成交额达2864.68万元,换手率为0.24%。近日,山东威高骨科材料股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示,公司定于2026年3月16日召开2026年第一次临时股东会,会议采取现场投票与网络投票相结合的方式,网络投票通过上海证券交易所系统进行。股权登记日为2026年3月9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604925543","title":"每周股票复盘:威高骨科(688161)拟出资6000万参投私募基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925543","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925543?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:49","pubTimestamp":1768679347,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,威高骨科报收于30.15元,较上周的30.13元上涨0.07%。本周,威高骨科1月14日盘中最高价报31.84元。1月12日盘中最低价报30.0元。威高骨科当前最新总市值120.6亿元,在医疗器械板块市值排名29/127,在两市A股市值排名1727/5183。本周关注点公司公告汇总:威高骨科拟作为有限合伙人认缴出资6,000万元参与投资设立嘉兴信威创盈股权投资合伙企业。公司将持续履行信息披露义务,提示投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603055502","title":"威高骨科(688161)披露与私募基金合作投资事项进展公告,1月13日股价上涨0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603055502","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603055502?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:47","pubTimestamp":1768297632,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘,威高骨科报收于30.95元,较前一交易日上涨0.26%,最新总市值为123.8亿元。该股当日开盘30.8元,最高31.53元,最低30.46元,成交额达9923.56万元,换手率为0.8%。公司近日发布公告称,山东威高骨科材料股份有限公司拟作为有限合伙人认缴出资6,000万元,参与投资设立嘉兴信威创盈股权投资合伙企业,占其认缴出资总额的20%。公司尚未实缴出资,合伙企业尚未完成基金备案,也无具体投资项目。公司将持续履行信息披露义务,提示投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300030379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600396130","title":"每周股票复盘:威高骨科(688161)拟变更募投项目收购杰思拜尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2600396130","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600396130?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:00","pubTimestamp":1767297639,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,威高骨科报收于28.31元,较上周的28.15元上涨0.57%。本周关注点公司公告汇总:威高骨科拟变更部分募投项目用于收购苏州杰思拜尔股权并对其增资。公司公告汇总山东威高骨科材料股份有限公司于2025年12月29日召开2025年第三次临时股东会,审议通过《关于变更部分募投项目暨收购苏州杰思拜尔医疗科技有限公司股权并对其增资的议案》及增补李进取先生为第三届董事会非独立董事的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595736979","title":"威高骨科(688161)披露变更部分募投项目并收购苏州杰思拜尔股权,12月29日股价下跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595736979","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595736979?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:52","pubTimestamp":1767019938,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘,威高骨科报收于28.17元,较前一交易日下跌0.49%,最新总市值为112.68亿元。该股当日开盘28.2元,最高28.38元,最低28.15元,成交额达1915.11万元,换手率为0.17%。公司近日发布公告称,于2025年12月29日召开2025年第三次临时股东会,审议通过《关于变更部分募投项目暨收购苏州杰思拜尔医疗科技有限公司股权并对其增资的议案》。会议由董事会召集,采用现场与网络投票相结合的方式进行,出席会议的股东共53名,代表有表决权股份总数的83.9587%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593485246","title":"威高骨科(688161)披露拟变更部分募投项目用于收购杰思拜尔55%股权,12月22日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485246?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:53","pubTimestamp":1766397191,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,威高骨科报收于28.1元,较前一交易日下跌0.18%,最新总市值为112.4亿元。该股当日开盘28.2元,最高28.27元,最低27.74元,成交额达4193.28万元,换手率为0.37%。近日,威高骨科发布2025年第三次临时股东会会议资料,其中披露一项重要议案:公司拟变更‘研发中心建设项目’中8,646万元未使用募集资金,用于收购苏州杰思拜尔医疗科技有限公司55%股权并对其增资,交易对价合计8,646万元。本次交易不构成关联交易或重大资产重组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592161449","title":"威高骨科(688161)披露设立募集资金专项账户议案,12月17日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592161449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592161449?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:45","pubTimestamp":1765982711,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘,威高骨科报收于27.74元,较前一交易日上涨0.91%,最新总市值为110.96亿元。该股当日开盘27.31元,最高27.77元,最低27.21元,成交额达2373.54万元,换手率为0.22%。公司近日发布公告称,山东威高骨科材料股份有限公司于2025年12月17日召开第三届董事会第十八次会议,审议通过《关于设立募集资金专项账户并签订募集资金三方监管协议的议案》。表决结果为8票同意,0票反对,0票弃权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700040426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590151422","title":"威高骨科(688161)披露拟变更部分募投项目并收购杰思拜尔股权,12月11日股价下跌1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590151422","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590151422?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:36","pubTimestamp":1765463782,"startTime":"0","endTime":"0","summary":"截至2025年12月11日收盘,威高骨科报收于28.08元,较前一交易日下跌1.06%,最新总市值为112.32亿元。近日,威高骨科发布关于召开公司2025年第三次临时股东会的通知公告。公告显示,山东威高骨科材料股份有限公司将于2025年12月29日召开2025年第三次临时股东会,会议采取现场投票与网络投票相结合的方式,网络投票通过上海证券交易所系统进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100042371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777530136080,"stockEarnings":[{"period":"1week","weight":-0.0265},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0108},{"period":"1year","weight":0.0985},{"period":"ytd","weight":0.053}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东威高骨科材料股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9603人(较上一季度减少3.78%)","perCapita":"41653股","listingDate":"2021-06-30","address":"山东省威海市环翠区旅游度假区香江街26号","registeredCapital":"40000万元","survey":" 山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发,生产和销售。公司的主要产品是骨科植入物及耗材类产品、骨科智能设备与耗材类产品、功能修复与组织再生类产品。公司是国内产品线最全、规模领先的头部企业之一,市场份额增长远超行业平均增速。公司在国内市场上建立了较高的品牌知名度,在国产高端医疗器械领域具有较高的市场占有率。","listedPrice":36.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高骨科,688161,威高骨科股票,威高骨科股票老虎,威高骨科股票老虎国际,威高骨科行情,威高骨科股票行情,威高骨科股价,威高骨科股市,威高骨科股票价格,威高骨科股票交易,威高骨科股票购买,威高骨科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}